Title : Prospects for the management of non-Hodgkin's lymphomas with monoclonal antibodies and immunoconjugates.

Pub. Date : 1998 Jul

PMID : 9672771






2 Functional Relationships(s)
Download
Sentence
Compound Name
Protein Name
Organism
1 Complete remissions (CRs) appear to be more frequent and durable with radiolabeled anti-CD20 antibodies (33% to 85% CR rate) than with unmodified chimeric anti-CD20 antibodies (6% to 10% CR rate), although a randomized comparison has not yet been made. Chromium keratin 20 Homo sapiens
2 Complete remissions (CRs) appear to be more frequent and durable with radiolabeled anti-CD20 antibodies (33% to 85% CR rate) than with unmodified chimeric anti-CD20 antibodies (6% to 10% CR rate), although a randomized comparison has not yet been made. Chromium keratin 20 Homo sapiens